KCK Ltd.
- SEC CIK
- 0001657662
- Latest filing
- Oct 14, 2025
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 11, 2022. Long positions only.
- Positions
- 4
- No filing for Q3 2021
- Portfolio value
- $141.6M
- No filing for Q3 2021
KCK Ltd. did not file a 13F for Q3 2021, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SGHTSight Sciences, Inc. | COM | 4,776,232 | $83.9M | 59.3% | – | – | History |
| NPCENeuroPace Inc | COM | 5,621,111 | $56.7M | 40.0% | – | – | History |
| IMUXImmunic, Inc. | COM | 69,704 | $667.0K | 0.5% | – | – | History |
| RNTXRein Therapeutics, Inc. | COM | 646,817 | $362.0K | 0.3% | – | – | History |